Literature DB >> 24268987

Delayed myelination is not a constant feature of Allan-Herndon-Dudley syndrome: report of a new case and review of the literature.

Sara Azzolini1, Margherita Nosadini2, Marta Balzarin1, Stefano Sartori2, Agnese Suppiej2, Rodica Mardari3, Nella Augusta Greggio1, Irene Toldo4.   

Abstract

INTRODUCTION: Allan-Herndon-Dudley syndrome is an X-linked condition caused by mutations of the monocarboxylate transporter 8 gene. This syndrome is characterized by axial hypotonia, severe mental retardation, dysarthria, athetoid movements, spastic paraplegia, and a typical thyroid hormone profile. In most of the cases reported so far, brain magnetic resonance imaging showed delayed myelination of the central white matter and this finding greatly affects the diagnosis of the syndrome. CASE REPORT: We present a new case studied with magnetic resonance imaging and spectroscopy and we reviewed all the articles published between 2004 and 2012 containing information on brain neuroimaging in this syndrome. An Italian boy, showing a classical phenotype of the syndrome, was diagnosed at 17months of age. Genetic analysis revealed a new frameshift mutation of the monocarboxylate transporter 8 gene. His brain magnetic resonance imaging and spectroscopy, performed at the age of 14months, were normal. DISCUSSION: Among the 33 cases reported in the literature, 3 cases had normal neuroimaging and in 7 of 14 cases, having a longitudinal follow-up, the initial finding of delayed myelination gradually improved. Our case and the review of the pertinent literature suggest that Allan-Herndon-Dudley syndrome should be suspected in males with the typical neurological and thyroid profile, even in cases with normal brain myelination.
Copyright © 2013 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Allan–Herndon–Dudley syndrome; Brain magnetic resonance imaging; Central hypotonia; Monocarboxylate transporter 8; SLC16A2 gene; Thyroid hormone

Mesh:

Substances:

Year:  2013        PMID: 24268987     DOI: 10.1016/j.braindev.2013.10.009

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  4 in total

Review 1.  Thyroid hormone transporters--functions and clinical implications.

Authors:  Juan Bernal; Ana Guadaño-Ferraz; Beatriz Morte
Journal:  Nat Rev Endocrinol       Date:  2015-05-05       Impact factor: 43.330

2.  Heterozygous Variants in the Mechanosensitive Ion Channel TMEM63A Result in Transient Hypomyelination during Infancy.

Authors:  Huifang Yan; Guy Helman; Swetha E Murthy; Haoran Ji; Joanna Crawford; Thomas Kubisiak; Stephen J Bent; Jiangxi Xiao; Ryan J Taft; Adam Coombs; Ye Wu; Ana Pop; Dongxiao Li; Linda S de Vries; Yuwu Jiang; Gajja S Salomons; Marjo S van der Knaap; Ardem Patapoutian; Cas Simons; Margit Burmeister; Jingmin Wang; Nicole I Wolf
Journal:  Am J Hum Genet       Date:  2019-10-03       Impact factor: 11.025

Review 3.  Monocarboxylate Transporter 8 Deficiency: Delayed or Permanent Hypomyelination?

Authors:  Pieter Vancamp; Barbara A Demeneix; Sylvie Remaud
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-13       Impact factor: 5.555

4.  Regional Difference in Myelination in Monocarboxylate Transporter 8 Deficiency: Case Reports and Literature Review of Cases in Japan.

Authors:  Hideyuki Iwayama; Tatsushi Tanaka; Kohei Aoyama; Masaharu Moroto; Shinsuke Adachi; Yasuko Fujisawa; Hiroki Matsuura; Kyoko Takano; Haruo Mizuno; Akihisa Okumura
Journal:  Front Neurol       Date:  2021-07-15       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.